-transparent.png){kind=logo}
Indomethacin and alclofenac were compared for 13 months under double-blind conditions in 109 patients with active, classical, or definite rheumatoid arthritis at a relatively early stage of the disease. Both indomethacin and alclofenac were clearly effective: most patients either improved or remained as well controlled as on entry. Alclofenac proved the more effective drug, however, producing a significantly greater reduction in morning stiffness, articular index, and erythrocyte sedimentation rate, and only in the alclofenac-treated group did functional capacity improve and latex-agglutination titres diminish. Comprehensive laborabory tests showed no significant deviation from normal which could have been attributed to either drug.
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
April 1978,
British medical journal,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
January 1973,
Current medical research and opinion,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
November 1971,
Arzneimittel-Forschung,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
January 1975,
Current medical research and opinion,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
September 1972,
La Clinica terapeutica,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
June 1971,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
April 1982,
Ryumachi. [Rheumatism],
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
January 1976,
Current medical research and opinion,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
November 1967,
Arzneimittel-Forschung,
M Aylward, and
R J Parker, and
F Holly, and
J Maddock, and
D B Davies
June 1985,
The Journal of rheumatology,
